Sponsored
Heidi Casaletto, Vice President of Global Marketing, Catalent, comments on the significance of developing biologics with a 'patient first' philosphy.
Heidi Casaletto
Advertisement
Articles by Heidi Casaletto
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
2
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
3
Everything to Know about BMS & NVidia’s AI Supercomputer
4
PharmTech Weekly Roundup—July 17, 2026
5